A detailed history of Liberty Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Liberty Capital Management, Inc. holds 37,358 shares of ABBV stock, worth $6.22 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
37,358
Previous 37,787 1.14%
Holding current value
$6.22 Million
Previous $5.86 Million 16.17%
% of portfolio
1.69%
Previous 1.54%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $68,562 - $78,120
-429 Reduced 1.14%
37,358 $6.8 Million
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $129,344 - $145,671
940 Added 2.55%
37,787 $5.86 Million
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $537,699 - $622,466
4,025 Added 12.26%
36,847 $5.49 Million
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $123,499 - $153,686
932 Added 2.92%
32,822 $4.42 Million
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $30,657 - $35,306
-212 Reduced 0.66%
31,890 $5.08 Million
Q4 2022

Jan 23, 2023

BUY
$138.31 - $165.87 $62,654 - $75,139
453 Added 1.43%
32,102 $0
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $2.61 Million - $2.99 Million
19,429 Added 158.99%
31,649 $4.25 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $2.6 Million - $2.98 Million
-19,383 Reduced 61.33%
12,220 $1.64 Million
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $104,591 - $132,969
-760 Reduced 2.35%
31,603 $4.84 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $225,289 - $279,521
1,707 Added 5.57%
32,363 $5.25 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $192,621 - $243,722
-1,793 Reduced 5.53%
30,656 $4.15 Million
Q3 2021

Oct 22, 2021

BUY
$106.4 - $120.78 $1,064 - $1,207
10 Added 0.03%
32,449 $3.5 Million
Q2 2021

Jul 16, 2021

SELL
$105.21 - $117.21 $53,972 - $60,128
-513 Reduced 1.56%
32,439 $3.65 Million
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $254,215 - $279,860
2,485 Added 8.16%
32,952 $3.57 Million
Q4 2020

Jan 20, 2021

BUY
$80.49 - $108.67 $126,369 - $170,611
1,570 Added 5.43%
30,467 $3.27 Million
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $7,850 - $10,505
-107 Reduced 0.37%
28,897 $2.84 Million
Q1 2020

Apr 13, 2020

BUY
$64.5 - $97.79 $49,665 - $75,298
770 Added 2.73%
29,004 $2.21 Million
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $3,606 - $4,512
50 Added 0.18%
28,234 $2.5 Million
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $5,794 - $6,966
92 Added 0.33%
28,184 $2.13 Million
Q2 2019

Jul 15, 2019

SELL
$65.7 - $83.98 $7,949 - $10,161
-121 Reduced 0.43%
28,092 $2.04 Million
Q1 2019

Apr 22, 2019

SELL
$77.14 - $90.79 $17,819 - $20,972
-231 Reduced 0.81%
28,213 $2.27 Million
Q4 2018

Jan 24, 2019

SELL
$77.85 - $96.01 $50,135 - $61,830
-644 Reduced 2.21%
28,444 $2.62 Million
Q3 2018

Oct 26, 2018

BUY
$88.91 - $98.84 $43,210 - $48,036
486 Added 1.7%
29,088 $2.75 Million
Q2 2018

Jul 17, 2018

BUY
$89.78 - $106.23 $34,834 - $41,217
388 Added 1.38%
28,602 $2.65 Million
Q1 2018

Apr 25, 2018

BUY
$92.01 - $123.21 $9,937 - $13,306
108 Added 0.38%
28,214 $2.67 Million
Q4 2017

Jan 16, 2018

SELL
$89.56 - $98.21 $49,258 - $54,015
-550 Reduced 1.92%
28,106 $2.82 Million
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $2 Million - $2.56 Million
28,656
28,656 $2.75 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Liberty Capital Management, Inc. Portfolio

Follow Liberty Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Capital Management, Inc. with notifications on news.